Clinical Trials in Denmark

• A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/… Not authorised
  2022-500410-26-00 Phase III Cystic Fibrosis University Medical Center Utrecht
• Senolytics to Improve Osteoporosis therapy: A randomised controlled clinical trial The SENIOR Trial Not authorised
  2022-500669-28-00 Phase II Osteoporosis Odense University Hospital
• STOP-COPD Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease Not authorised
  2022-500816-21-00 Phase IV Acute Exacerbation of Chronic Obstructive Pulmonary Disease Præhospitalet
• An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl… Not authorised
  2022-501006-34-00 Phase III Liver cirrhosis European Foundation For The Study Of Chronic Liver Failure; Odense University Ho…
• ITP BLOCK FOR MINOR BREAST CANCER SURGERY Not authorised
  2022-501312-34-00 Phase IV Breast cancer Zealand University Hospital
• Phase 3 Study Assessing Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Orbit) Not authorised
  2022-501535-16-00 Phase III Atopic Dermatitis (AD) Amgen Inc.
• A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised
  2022-501644-15-00 Phase II Mild Cognitive Impairment due to Alzheimer's Disease Alzheim… Biogen Idec Research Limited
• A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Not authorised
  2022-502781-24-00 Phase III/IV ASCVD - Atherosclerotic Cardiovascular Disease Merck Sharp & Dohme LLC
• A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext… Not authorised
  2022-502877-41-00 Phase I/II Pulmonary sarcoidosis with or without extrapulmonary manifes… Xentria Inc.
• A Phase I Study of RO7589831 in Participants with Advanced Solid Tumors Not authorised
  2023-503170-20-00 Phase I Advanced solid tumors F. Hoffmann-La Roche AG
• Boosting recovery through excitation of arousal and awareness in comatose patients (BREA2KTHROUGH) Not authorised
  2023-503617-30-01 Phase I/II Coma and other disorders of consciousness due to acute traum… Rigshospitalet
• A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Not authorised
  2023-503631-18-00 Phase III Nervous system diseases Sanofi-Aventis Research & Development
• [68Ga]Ga-FAPI total body PET/CT for improving diagnostic sensitivity and preoperative staging in gastroesophageal cancer and pancreatic canc… Not authorised
  2023-503632-41-00 Phase II Pancreatic cancer and gastroesophageal cancer (esophagus, ga… Rigshospitalet
• Effect of Allogenic Ex-vivo Expanded Bone Marrow Derived Mesenchymal Stem Cells on Knee Osteoarthritis – A Randomized Controlled Trial Not authorised
  2023-503974-19-00 Phase II/III Osteoarthritis in knee joint Odense University Hospital
• Safety and efficacy of oral semaglutide in hyperglycaemic patients after renal transplantation Not authorised
  2023-504159-29-00 Phase II Hyperglycaemia after renal transplantation Rigshospitalet
• Phase 1b/2a Study to Evaluate Alnuctamab in Combination with Mezigdomide in Relapsed and/or Refractory Multiple Myeloma. Not authorised
  2023-504367-16-00 Phase II Relapsed and/or Refractory Multiple Myeloma Celgene International II S.a.r.l.
• ASPIRE-1: dApagliflozin SC0062 and Prevention of renal Injury; a Randomized Evaluation Not authorised
  2023-504404-28-00 Phase II Chronic Kidney Disease University Medical Center Groningen
• Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle… Not authorised
  2023-504616-15-00 Phase III Infertility Region Midtjylland
• Safety, tolerability, and efficacy of mFOLFIRINOX ±BNT321 as adjuvant therapy following curative resection in patients with pancreatic adeno… Not authorised
  2023-506014-47-00 Phase I/II Resected (R0 or R1) pancreatic ductal adenocarcinoma BioNTech SE
• Allogenic mesenchymal stem cell intraarticular injection for knee osteoarthritis therapy, an RCT explorative mode-of-action study Not authorised
  2023-506088-33-00 Phase I/II knee osteoarthritis Aarhus University
• A study to assess the efficacy and safety of OATD-01 for the treatment of active pulmonary sarcoidosis. Not authorised
  2023-506642-23-00 Phase II Active Pulmonary Sarcoidosis Molecure S.A.
• LIGHTBEAM-U01 Substudy 01B: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Pembrolizumab in Combination with Investigational Ag… Not authorised
  2023-507179-23-00 Phase I/II Hematologic Malignancies or Solid Tumors in Pediatric and Yo… Merck Sharp & Dohme LLC
• Clinical validation study of urinary clusterin and EGF in patients with chronic kidney disease Not authorised
  2023-507449-27-00 Phase IV Chronic kidney disease Steno Diabetes Center Copenhagen
• An ascending dose study to determine the safety and effect of antibodies against hepatitis B (The SAMBA Study) Not authorised
  2023-508444-22-00 Phase I Chronic hepatitis B infection Region Midtjylland

Showing 1–24 of 1,481 trials